Clinical Trial Update: Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma [Phase 1]

View source ↗

Summary

A phase 1 clinical trial update evaluating selinexor as maintenance therapy after CAR-T cell therapy in multiple myeloma, currently recruiting. The sponsor is W…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING